These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4726484)

  • 1. Glucagon treatment for muscular dystrophy in the mouse.
    Pope RS
    Am J Physiol; 1973 Sep; 225(3):518-20. PubMed ID: 4726484
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of muscular dystrophy.
    Bradley WG; Polgar JG; Williams MH; Boddie HG
    Br Med J; 1972 Sep; 3(5828):699-700. PubMed ID: 4650857
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagon treatment of muscular dystrophic mice: a lack of effect.
    Yen TT; Allan JA
    Experientia; 1974 Aug; 30(8):908. PubMed ID: 4413580
    [No Abstract]   [Full Text] [Related]  

  • 4. Bortezomib partially improves laminin α2 chain-deficient muscular dystrophy.
    Körner Z; Fontes-Oliveira CC; Holmberg J; Carmignac V; Durbeej M
    Am J Pathol; 2014 May; 184(5):1518-28. PubMed ID: 24631023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is muscular dystrophy a primary myopathy?
    Pope RS
    Perspect Biol Med; 1975; 18(2):287-91. PubMed ID: 1196832
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug evaluation in muscular dystrophy of the chicken.
    Entrikin RK; Patterson GT; Wilson BW
    Muscle Nerve; 1982 Apr; 5(4):321-7. PubMed ID: 7099198
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic trials in muscular dystrophy. 1. Gold in murine dystrophy.
    Enomoto A; Bradley WG
    J Neurol Neurosurg Psychiatry; 1978 May; 41(5):404-7. PubMed ID: 96218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive effects of bisphosphonates on bone and muscle in a mouse model of Duchenne muscular dystrophy.
    Yoon SH; Sugamori KS; Grynpas MD; Mitchell J
    Neuromuscul Disord; 2016 Jan; 26(1):73-84. PubMed ID: 26494410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anticancer drug tamoxifen counteracts the pathology in a mouse model of duchenne muscular dystrophy.
    Dorchies OM; Reutenauer-Patte J; Dahmane E; Ismail HM; Petermann O; Patthey- Vuadens O; Comyn SA; Gayi E; Piacenza T; Handa RJ; Décosterd LA; Ruegg UT
    Am J Pathol; 2013 Feb; 182(2):485-504. PubMed ID: 23332367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Some indices of energy metabolism in the tissues of mice with progressive muscular dystrophy under the action of ubiquinone].
    Monakhov NK; Obol'nikova EA; Igdal LG; Torosian ZhK; Antelava NA
    Vopr Med Khim; 1974 May; 20(3):276-84. PubMed ID: 4275937
    [No Abstract]   [Full Text] [Related]  

  • 11. Contractile properties of soleus muscle during development in normal and dystrophic mice.
    Taylor RG; Fowler WM; Mason DT
    Arch Phys Med Rehabil; 1974 Dec; 55(12):531-9. PubMed ID: 4429430
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental animal information file: effect of bestatin in muscular dystrophy in mice].
    Kawamata J
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2425-6. PubMed ID: 6639104
    [No Abstract]   [Full Text] [Related]  

  • 13. Dysferlin-deficient muscular dystrophy: gadofluorine M suitability at MR imaging in a mouse model.
    Schmidt S; Vieweger A; Obst M; Mueller S; Gross V; Gutberlet M; Steinbrink J; Taubert S; Misselwitz B; Luedemann L; Spuler S
    Radiology; 2009 Jan; 250(1):87-94. PubMed ID: 19001151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
    Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
    J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retardation of symptoms of dystrophy in genetically dystrophic chickens by chemotherapy.
    Hudecki MS; Barnard EA
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):167-76. PubMed ID: 935649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of spider Latrodectus tredecimguttatus poison on progressive muscular dystrophy in rat.
    Stern P; Valjevac K; Gmaz-Nikulin E
    Arzneimittelforschung; 1975 May; 25(5):769-71. PubMed ID: 1242318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models of muscle diseases, Part III: Compilation of therapeutic trials for hereditary muscular dystrophy.
    Cosmos E; Butler J
    Muscle Nerve; 1980; 3(5):427-35. PubMed ID: 7421876
    [No Abstract]   [Full Text] [Related]  

  • 18. Beneficial effects of penicillamine treatment on hereditary avian muscular dystrophy.
    Chou T; Hill EJ; Bartle E; Woolley K; LeQuire V; Olson W; Roelofs R; Park JH
    J Clin Invest; 1975 Oct; 56(4):842-9. PubMed ID: 1159090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional improvement of dystrophic muscle by myostatin blockade.
    Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
    Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of genetically dystrophic animals in chemotherapy trials and application of serotonin antagonists as antidystrophic drugs.
    Barnard EA; Barnard PJ
    Ann N Y Acad Sci; 1979; 317():374-99. PubMed ID: 289319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.